The autonomously functioning thyroid nodule: Goetsch's disease

Area of Science:

• Endocrinology
• Thyroidology
• Pathology

Background:

• Autonomously functioning thyroid nodules (AFTNs) were defined by Goetsch in 1918, linking mitochondrial content to nodular function.
• AFTNs exhibit an inverse correlation between nodular and extranodular thyroid tissue function.
• Degenerative changes within AFTNs can influence the development, resolution, or transient induction of hyperthyroidism.

Purpose of the Study:

• To review the clinical characteristics and management of autonomously functioning thyroid nodules (AFTNs).
• To differentiate between toxic and nontoxic AFTNs and discuss diagnostic modalities.
• To outline treatment strategies for toxic AFTNs based on patient demographics.

Main Methods:

• Clinical evaluation, including serum T3 assays and TRH testing, for assessing AFTN function.
• Suppression imaging to determine if warm nodules are AFTNs.
• Review of existing literature regarding AFTN diagnosis and management.

Main Results:

• AFTNs are predominantly benign, with limited evidence supporting malignancy in most reported cases.
• Degeneration within AFTNs can lead to varied effects on thyroid hormone levels, including hyperthyroidism.
• Diagnostic methods can effectively determine AFTN toxicity and guide treatment decisions.

Conclusions:

• Nontoxic AFTNs are typically managed with observation, with prophylactic therapy considered for specific patient groups.
• Toxic AFTNs require treatment, with surgery recommended for younger patients (<40 years) and radioactive iodine therapy for older patients.
• High-dose radioactive iodine therapy is the preferred treatment for toxic AFTNs due to its consistent efficacy in ablating nodular function.